Analyst Rating Changes — Upgrades, Downgrades & Price Targets

52645 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Rating Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Aug 13 00:18 UTC	CAVA CAVA Group	◎ Target	Wolfe Research	Margaret-May Binshtok not yet tracked	Outperform	$79.00→ $82.00+3.8%
Aug 13 00:18 UTC	CAVA CAVA Group	◎ Target	TD Cowen	Andrew M. not yet tracked	Buy	$100.00→ $85.00-15.0%
Aug 13 00:18 UTC	CAVA CAVA Group	◎ Target	Mizuho	Nick Setyan ★★★★☆ #940	Neutral	$85.00→ $70.00-17.6%
Aug 13 00:18 UTC	CARG CarGurus	◎ Target	Oppenheimer	Jed Kelly ★★★☆☆ #1648	Outperform	$38.00→ $44.00+15.8%
Aug 13 00:18 UTC	CAH Cardinal Health	◎ Target	Morgan Stanley	Erin Wright ★★★★☆ #480	Overweight	$255.00→ $265.00+3.9%
Aug 13 00:18 UTC	CAH Cardinal Health	◎ Target	UBS Group	Kevin Caliendo ★★★★☆ #573	Buy	$274.00→ $280.00+2.2%
Aug 13 00:18 UTC	CAH Cardinal Health	◎ Target	Mizuho	Steven Valiquette ★★★☆☆ #1593	Outperform	$240.00→ $250.00+4.2%
Aug 13 00:18 UTC	CAH Cardinal Health	◎ Target	Citigroup	Daniel Grosslight ★★★☆☆ #1225	Buy	$265.00→ $280.00+5.7%
Aug 13 00:18 UTC	CAH Cardinal Health	◎ Target	Wells Fargo & Company	Stephen Baxter ★★★★★ #281	Overweight	$245.00→ $277.00+13.1%
Aug 13 00:18 UTC	CAH Cardinal Health	◎ Target	Robert W. Baird	Eric Coldwell ★★★★☆ #747	Outperform	$251.00→ $274.00+9.2%
Aug 13 00:18 UTC	BWY Bellway	◎ Target	Jefferies Financial Group	firm only	Buy	GBX 2,394→ GBX 2,380-0.6%
Aug 13 00:18 UTC	BWY Bellway	◎ Target	Citigroup	firm only	Buy	GBX 2,300→ GBX 2,500+8.7%
Aug 13 00:18 UTC	BWAY Brainsway	◎ Target	BTIG Research	Sam Eiber ★★★☆☆ #1950	Buy	$18.00→ $20.00+11.1%
Aug 13 00:18 UTC	BRCB Black Rock Coffee Bar	◎ Target	DA Davidson	Matt Curtis ★★★☆☆ #1877	Buy	$15.00→ $10.00-33.3%
Aug 13 00:18 UTC	BRBY Burberry Group	◎ Target	Citigroup	firm only	Buy	GBX 1,560→ GBX 1,510-3.2%
Aug 13 00:18 UTC	BNS Bank of Nova Scotia	◎ Target	TD	firm only	Hold	C$113.00→ C$124.00+9.7%
Aug 13 00:18 UTC	BNS Bank of Nova Scotia	◎ Target	Raymond James Financial	firm only	Outperform	C$121.00→ C$137.00+13.2%
Aug 13 00:18 UTC	BMO Bank of Montreal	◎ Target	Raymond James Financial	firm only	Outperform	C$233.50→ C$268.00+14.8%
Aug 13 00:18 UTC	BMO Bank of Montreal	◎ Target	TD	firm only	Buy	C$239.00→ C$263.00+10.0%
Aug 13 00:18 UTC	BMBL Bumble	◎ Target	UBS Group	Stephen Ju ★★☆☆☆ #2489	Neutral	$4.50→ $3.00-33.3%
Aug 13 00:18 UTC	BLTE Belite Bio	◎ Target	HC Wainwright	Yi Chen ★★☆☆☆ #2429	Buy	$200.00→ $214.00+7.0%
Aug 13 00:18 UTC	BKKT Bakkt	◎ Target	Benchmark	Mark Palmer ★★★★☆ #755	Buy	$19.00→ $12.00-36.8%
Aug 13 00:18 UTC	BHVN Biohaven	◎ Target	Morgan Stanley	Terence Flynn ★★★★☆ #866	Overweight	$18.00→ $19.00+5.6%
Aug 13 00:18 UTC	BHST BioHarvest Sciences	◎ Target	Roth Capital	Sean McGowan ★☆☆☆☆ #2954	Buy	$10.00→ $8.00-20.0%
Aug 13 00:18 UTC	BHST BioHarvest Sciences	◎ Target	Maxim Group	Anthony Vendetti ★☆☆☆☆ #3194	Buy	$12.00→ $5.00-58.3%
Aug 13 00:18 UTC	BGS B&G Foods	◎ Target	TD Cowen	Robert Moskow ★★★★☆ #500	Sell	$4.00→ $3.00-25.0%
Aug 13 00:18 UTC	BGEO Lion Finance Group	◎ Target	JPMorgan Chase & Co.	firm only	Overweight	£139→ £141+1.4%
Aug 13 00:18 UTC	BCSF Bain Capital Specialty Finance	◎ Target	Wells Fargo & Company	Finian O'Shea ★★★☆☆ #1688	Equal Weight	$13.00→ $12.00-7.7%
Aug 13 00:18 UTC	BCAX Bicara Therapeutics	◎ Target	Wedbush	David Nierengarten ★★★☆☆ #2127	Outperform	$30.00→ $33.00+10.0%
Aug 13 00:18 UTC	BCAX Bicara Therapeutics	◎ Target	Mizuho	Joseph Catanzaro ★★☆☆☆ #2485	Neutral	$18.00→ $20.00+11.1%
Aug 13 00:18 UTC	BCAX Bicara Therapeutics	◎ Target	The Goldman Sachs Group	Richard Law not yet tracked	Neutral	$18.00→ $20.00+11.1%
Aug 13 00:18 UTC	BCAX Bicara Therapeutics	◎ Target	Wells Fargo & Company	Eva Fortea Verdejo ★★★★☆ #820	Equal Weight	$16.00→ $23.00+43.8%
Aug 13 00:18 UTC	BCAX Bicara Therapeutics	◎ Target	BTIG Research	Jeet Mukherjee ★★★☆☆ #2206	Buy	$28.00→ $39.00+39.3%
Aug 13 00:18 UTC	BBOX Tritax Big Box REIT	◎ Target	JPMorgan Chase & Co.	firm only	Overweight	GBX 180→ GBX 190+5.6%
Aug 13 00:18 UTC	BBIO BridgeBio Pharma	◎ Target	Truist Financial	Danielle Brill ★★★☆☆ #2088	Buy	$102.00→ $107.00+4.9%
Aug 13 00:18 UTC	BBIO BridgeBio Pharma	◎ Target	JPMorgan Chase & Co.	Anupam Rama ★★☆☆☆ #2747	Overweight	$100.00→ $111.00+11.0%
Aug 13 00:18 UTC	BBIO BridgeBio Pharma	◎ Target	Canaccord Genuity Group	Whitney Ijem ★★☆☆☆ #2814	Buy	$104.00→ $106.00+1.9%
Aug 13 00:18 UTC	B Barrick Mining	◎ Target	Scotiabank	Tanya Jakusconek ★★☆☆☆ #2297	Sec→ r Outperform	$57.00→ $55.00-3.5%
Aug 13 00:18 UTC	AXSM Axsome Therapeutics	◎ Target	Mizuho	Graig Suvannavejh ★★☆☆☆ #2757	Outperform	$306.00→ $316.00+3.3%
Aug 13 00:18 UTC	AXP American Express	◎ Target	Piper Sandler	Bill Carcache not yet tracked	Overweight	$396.00→ $405.00+2.3%
Aug 13 00:18 UTC	ATI ATI	◎ Target	KeyCorp	Michael Leshock ★☆☆☆☆ #3060	Overweight	$211.00→ $258.00+22.3%
Aug 13 00:18 UTC	ARMK Aramark	◎ Target	Jefferies Financial Group	Stephanie Moore ★★☆☆☆ #2456	Buy	$62.00→ $70.00+12.9%
Aug 13 00:18 UTC	ARMK Aramark	◎ Target	Stifel Nicolaus	Shlomo Rosenbaum ★★★★★ #153	Buy	$54.00→ $70.00+29.6%
Aug 13 00:18 UTC	ARMK Aramark	◎ Target	UBS Group	Joshua Chan ★★★☆☆ #1530	Buy	$67.00→ $71.00+6.0%
Aug 13 00:18 UTC	ARMK Aramark	◎ Target	Robert W. Baird	Andrew Wittmann ★★★★☆ #416	Outperform	$63.00→ $69.00+9.5%
Aug 13 00:18 UTC	AR Antero Resources	◎ Target	Benchmark	Subash Chandra ★★☆☆☆ #2577	Buy	$44.00→ $47.00+6.8%
Aug 13 00:18 UTC	APP AppLovin	◎ Target	BTIG Research	Clark Lampen ★★☆☆☆ #2744	Buy	$574.00→ $408.00-28.9%
Aug 13 00:18 UTC	APC Anadarko Petroleum	◎ Target	UBS Group	Josh Silverstein ★★★☆☆ #1591	Buy	$22.00→ $21.00-4.5%
Aug 13 00:18 UTC	APA APA	◎ Target	Benchmark	Subash Chandra ★★☆☆☆ #2577	Buy	$40.00→ $46.00+15.0%
Aug 13 00:18 UTC	ANF Abercrombie & Fitch	◎ Target	UBS Group	Mauricio Serna ★★★★★ #290	Buy	$136.00→ $153.00+12.5%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Rating Changes

Frequently Asked Questions

Welcome to 13Foresight!